Loading...
XNAS
GNTA
Market cap14mUSD
Oct 08, Last price  
0.71USD
1D
-5.95%
1Q
-52.66%
IPO
-93.69%
Name

Genenta Science SPA

Chart & performance

D1W1MN
XNAS:GNTA chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
1.70%
Rev. gr., 5y
%
Revenues
0
Net income
-6m
L-32.63%
-4,532,430-5,203,550-5,764,106-8,279,712-11,440,590-9,309,891-6,272,111
CFO
-7m
L+10.06%
-2,490,187-6,044,581-6,958,174-7,418,236-11,205,023-6,240,174-6,867,959

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
IPO date
Dec 15, 2021
Employees
4
Domiciled in
IT
Incorporated in
IT
Headquarters & legal address
VIA DELL'ANNUNCIATA, 31 (MILANO)
MILANO, MI 20121
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT